WuXi AppTec Co Ltd
SSE:603259
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
36.87
84.24
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
WuXi AppTec Co Ltd
Accounts Payable
WuXi AppTec Co Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
WuXi AppTec Co Ltd
SSE:603259
|
Accounts Payable
ÂĄ2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
||
Pharmaron Beijing Co Ltd
SZSE:300759
|
Accounts Payable
ÂĄ503m
|
CAGR 3-Years
23%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
||
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Accounts Payable
ÂĄ3.1B
|
CAGR 3-Years
79%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
||
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Accounts Payable
ÂĄ227.1m
|
CAGR 3-Years
22%
|
CAGR 5-Years
46%
|
CAGR 10-Years
31%
|
||
M
|
MGI Tech Co Ltd
SSE:688114
|
Accounts Payable
ÂĄ158.1m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Accounts Payable
ÂĄ620.5m
|
CAGR 3-Years
417%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
Glance View
WuXi AppTec Co., Ltd. is a prominent global healthcare platform that plays a pivotal role in empowering the pharmaceutical, biotechnology, and medical device industries. Founded in 2000 and headquartered in Shanghai, WuXi has cultivated a reputation for excellence through its extensive suite of services, which span the entire drug development lifecycle. From drug discovery to manufacturing, the company leverages cutting-edge technologies and a rich network of expertise to facilitate the development of innovative therapeutics. This comprehensive capability enables WuXi to serve as a trusted partner for clients, helping to streamline the complex path from concept to commercialization. With a focus on innovation and quality, WuXi AppTec has distinguished itself in the competitive landscape of contract research organizations (CROs) and contract manufacturing organizations (CMOs). The company's robust growth trajectory is underpinned by strategic investments in technology and infrastructure, as well as a commitment to expanding its global footprint. WuXi's expansive service offerings not only enhance operational efficiency for its partners but also align with the increasing demand for faster and more cost-effective drug development solutions. For investors, WuXi signifies an opportunity to engage with a market leader poised to capitalize on the burgeoning biopharmaceutical sector, driven by rising global healthcare needs and transformative advancements in science and technology.
See Also
What is WuXi AppTec Co Ltd's Accounts Payable?
Accounts Payable
2B
CNY
Based on the financial report for Jun 30, 2024, WuXi AppTec Co Ltd's Accounts Payable amounts to 2B CNY.
What is WuXi AppTec Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
34%
Over the last year, the Accounts Payable growth was -3%. The average annual Accounts Payable growth rates for WuXi AppTec Co Ltd have been 15% over the past three years , 34% over the past five years .